IRF1 and lung carcinoma: Myricetin was found to directly bind to Jak1 [47] and has been reported to prevent the phosphorylation of STAT1 and inhibit both the expression and nuclear translocation of IRF1 to suppress IFN-γ-induced IDO1 expression in human lung cancer cells [48].